SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
141.60    -24.20 (-14.60%)
Bid:
140.20
Ask:
144.80
Spread: 4.60 (3.281%)
Market Cap: £241.94m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Trading Update

10 Jan 2019 07:00

RNS Number : 6695M
McBride PLC
10 January 2019
 

10 January 2019

 

McBride plc

 

Trading Update

 

McBride plc (the "Group"), the leading European manufacturer and supplier of Contract Manufactured and Private Label products for the domestic Household and professional cleaning and hygiene markets, today provides a trading update for the six months ended 31 December 2018.

 

The Group's first half continuing revenues at constant currency were 10.8% higher than the prior year. Excluding the benefit of first quarter revenues from Danlind, continuing underlying revenues were 6.0% higher. Underlying Household division sales were 5.9% higher, primarily as a result of higher sales in the East and UK regions (up 23.4% and 10.5% respectively).

 

As outlined in our recent AGM trading update, the first half year has seen raw material, packaging and logistics costs higher than anticipated, particularly in the second quarter. These have been partly mitigated by improved sales volumes and lower overheads. The pricing outlook for many of our key raw materials has improved recently and in the absence of this reversing significantly, the Board expects full year earnings to be in line with expectations, with full year profit delivery weighted to the second half.

The sale of the European Personal Care Liquids business was successfully completed during the second quarter and we continue to progress plans for the closure of our UK Aerosols factory in the second half year as expected. The integration of Danlind continued with our Danish factories transitioning onto the McBride ERP system in December.

 

The Group will announce its interim results for the six months ended 31 December 2018 on 21 February.

 

Rik De Vos, Chief Executive said;

 

"The Group has made significant strategic progress in the first half of this financial year completing the sale of Personal Care Liquids, integrating Danlind onto the McBride systems and managing our revenue growth. Margins remain our key focus at present and the recent improvement in the pricing outlook for raw materials following almost two years of significant inflation will see some recovery of the cumulative cost impact to the business. I remain confident that the Group continues to be well positioned to exploit the growth and margin opportunities in the remainder of this financial year and beyond."

 

 

For further information please contact:

 

McBride plc

Rik De Vos, Chief Executive Officer

0161 203 7570

Chris Smith, Chief Financial Officer

0161 203 7570

FTI Consulting

020 3727 1017

Ed Bridges, Nick Hasell

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

 

-Ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTQKLFBKFFLBBV
Date   Source Headline
2nd Jul 20102:45 pmRNSDirector/PDMR Shareholding
28th Jun 20105:17 pmRNSDirector/PDMR Shareholding
24th Jun 20107:00 amRNSPre-close Trading Statement
28th May 201010:49 amRNSTotal Voting Rights
24th May 20102:49 pmRNSHolding(s) in Company
14th May 20103:06 pmRNSDirector/PDMR Shareholding
13th May 20103:36 pmRNSDirector/PDMR Shareholding
29th Apr 20107:00 amRNSInterim Management Statement
15th Apr 20107:00 amRNSAppointment of Chief Executive Officer
14th Apr 20103:25 pmRNSHolding(s) in Company
6th Apr 20103:48 pmRNSHolding(s) in Company
30th Mar 20102:31 pmRNSDirector/PDMR Shareholding
22nd Mar 20109:12 amRNSTransaction in Own Shares
5th Mar 20103:32 pmRNSDirector/PDMR Shareholding
26th Feb 20101:40 pmRNSTotal Voting Rights
24th Feb 201012:08 pmRNSTransaction in Own Shares
24th Feb 201012:07 pmRNSDirector/PDMR Shareholding
22nd Feb 201011:55 amRNSDirector/PDMR Shareholding
18th Feb 20104:46 pmRNSDirector/PDMR Shareholding
4th Feb 20107:00 amRNSHalf Yearly Results
20th Jan 20102:52 pmRNSHolding(s) in Company
17th Dec 20097:00 amRNSPre Close Trading Statement
1st Dec 20094:11 pmRNSDirector/PDMR Shareholding
1st Dec 200912:58 pmRNSTotal Voting Rights
17th Nov 200912:31 pmRNSHolding(s) in Company
5th Nov 200910:01 amRNSHolding(s) in Company
3rd Nov 20093:15 pmRNSTotal Voting Rights
3rd Nov 20099:30 amRNSResignation of Chief Executive
27th Oct 20094:40 pmRNSResult of AGM
26th Oct 20097:00 amRNSAGM and Interim Management Statement
21st Oct 20094:11 pmRNSHolding(s) in Company
21st Oct 200910:00 amRNSCancellation of blocklisting
16th Oct 20099:57 amRNSHolding(s) in Company
12th Oct 200912:37 pmRNSAnnual Information Update
9th Oct 200910:40 amRNSShare Transactions
1st Oct 200911:06 amRNSHolding(s) in Company
30th Sep 200910:00 amRNSTotal Voting Rights
24th Sep 20093:11 pmRNSAnnual Report and Accounts
23rd Sep 200912:14 pmRNSTransaction in Own Shares
22nd Sep 200911:29 amRNSTransaction in Own Shares
17th Sep 20099:42 amRNSTotal Voting Rights
11th Sep 20095:57 pmRNSTransaction in Own Shares
7th Sep 20095:09 pmRNSDirector Appointment
3rd Sep 20097:00 amRNSPreliminary Results
3rd Aug 20097:00 amRNSAppointment of new Executive Director
27th Jul 200910:55 amRNSHolding(s) in Company
22nd Jul 200910:54 amRNSHolding(s) in Company
15th Jul 20094:22 pmRNSHolding(s) in Company
24th Jun 20097:00 amRNSPre Close Trading Statement
23rd Jun 20094:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.